Parth Mehrotra, Chief Executive Officer of Privia Health Group (NASDAQ:PRVA), reported the direct sale of 121,086 shares for a total of approximately $2.73 million in multiple open-market transactions completed on May 11, 2026, and May 12, 2026, according to an SEC Form 4 filing.
Transaction summary Transaction value based on SEC Form 4 weighted average purchase price ($22.56); post-transaction value based on the derived holdings value as of the May 12, 2026 market close
Key questions – How did this sale impact Mehrotra’s direct ownership in Privia Health Group? This transaction reduced Mehrotra’s direct stake by 21.80%, bringing his direct holdings down to 434,357 shares, which equates to an estimated 0.34% of outstanding shares as of the latest available data. – Was this sale part of a pattern or a deviation from Mehrotra’s historical activity? The 121,086 shares disposed is the largest single open-market sell event by Mehrotra on record and reflects an acceleration in sale size, which is attributable to the declining number of shares available for disposition following a series of prior transactions. – Did the transactions involve any indirect holdings, derivative securities, or option exercises?
No; according to the filing, all shares sold were held directly and there was no activity involving indirect holdings, trusts, or derivatives in this event. – What does the data suggest about the sustainability of future large sales? With Mehrotra’s direct holdings now at 434,357 shares and no indirect or derivative positions disclosed, continued sales at this recent scale would quickly exhaust available shares, indicating that trade sizes may decrease unless additional awards or grants are made. Company overview 1-year performance calculated using May 12, 2026, as the reference date.